Lertvivatpong, Nawachai
Inaba, Hiroto https://orcid.org/0000-0003-0605-7342
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA021765)
Foundation for the National Institutes of Health (CA21765)
American Lebanese Syrian Associated Charities
Article History
Received: 3 December 2025
Revised: 14 March 2026
Accepted: 1 April 2026
First Online: 27 April 2026
Competing interests
: Nawachai Lertvivatpong has no conflicts of interest relevant to the subject of this article. Hiroto Inaba participates in the advisory boards of Syndax and Jazz Pharmaceuticals.